YTHu78
YTHu78 is a KDM5B PROTAC-type degrader. YTHu78 induces KDM5B degradation via the ubiquitin-proteasome system and triggers apoptosis in MV-4-11 and MM.1S cell lines. YTHu78 exhibits significant antiproliferative activity against a variety of hematological cancer cell lines and can be used to study hematological cancers. (Pink: KDM5B ligand: (HY-116761); Blue: Thalidomide ligand: (HY-14658), Black + Pink: KDM5B ligand + linker: (HY-175145)).
(Pink: KDM5 ligand (HY-116761); Blue: Cereblon ligand (HY-14658); Black: linker).
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C33H28N8O6
- Peso molecular:632.63
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas PROTACs
MoreVer todos los productos específicos de isoformas Caspase
More
Actividad biológica
|
Cereblon |
KDM5B |
Caspase 3 |
YTHu78 (72 h) shows antiproliferative activity against MV-4-11, HL60, MM.1S and OCI-AML3 cells, with IC50s of 1.34 μM, 6.58 μM, 1.03 μM, 9.07 μM[1].
YTHu78 (0.03-20 μM, 1-24 h) reduces KDM5B protein levels through the proteasome-mediated pathway in MV-4-11 and MM.1S cells[1].
YTHu78 (0.03-20 μM, 48 h) induces lytic apoptosis dependent on caspase in MV-4-11 and MM.1S cells[1].
YTHu78 (72 h) exhibits negligible anti-proliferative effects against primary HUVEC, GM00637 fibroblasts, HaCaT keratinocytes, GES-1, and HEK293 cells, with IC50s >20 μM[1].
YTHu78 (72 h) shows limited antiproliferative effects on refractory solid tumors and modestly sensitive solid tumor models, including HCC, PDAC, gGBM, and TNBC cells, with IC50s >20 μM and Huh-7, HCC1937, PANC-1 cells, IC50s 6-20 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MV-4-11 cells, MM.1S cells
-
Concentration:0.03 μM, 0.08 μM, 0.25 μM, 0.74 μM, 2.2 μM, 5 μM, 6.7 μM, 20 μM
-
Incubation Time:1 h, 3 h, 6 h, 12 h, 24 h,48 h
-
Result:Induced KDM5B protein degradation at a concentration of 0.74 μM and depleted KDM5B in a time-dependent manner, with maximal degradation achieved after 12 hours of treatment at a concentration of 5 μM.
Increased H3K4me3 levels.
Activated Caspase-3, induced PARP cleavage, and upregulated cleaved-GSDMD and cleaved-GSDME after 48 h of 5 μM treatment.
-
Cell Line:MV-4-11 cells, MM.1S cells
-
Concentration:0.03 μM, 0.08 μM, 0.25 μM, 0.74 μM, 2.2 μM, 5 μM, 6.7 μM, 20 μM
-
Incubation Time:24 h
-
Result:Did not affect KDM5B mRNA levels at low doses, increased mRNA levels at high concentrations in MM.1S cells.
-
Cell Line:MV-4-11 cells, MM.1S cells
-
Concentration:0.03 μM, 0.08 μM, 0.25 μM, 0.74 μM, 2.2 μM, 5 μM, 6.7 μM, 20 μM
-
Incubation Time:48 h
-
Result:Increased apoptotic population, induced mild G0/G1 cell cycle arrest at high doses, and increased LDH release.
Chemical Information
-
Peso molecular 632.63
-
Fòrmula C33H28N8O6
-
SMILES
O=C1NC(OC2=CN(CC3=CC=C(CCCNC4=CC=CC(C(N5C6CCC(NC6=O)=O)=O)=C4C5=O)C=C3)N=C2)=NC7=CN=CC=C71
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)